Drugmaker Hikma Pharmaceuticals said trading in its generics unit was below its expectations due to slower-than-anticipated growth in the sales of its gout drug and cut its full-year revenue forecast for the unit.
Hikma now expect
Britons are taking more prescription drugs than ever but the state health service is paying less for them - cheering news for taxpayers, if not for drugmakers.
The trend reflects an increased use of generic medicines amid a Europe-wide
Several generic drugmakers have launched cheap copies of AstraZeneca's top-selling heartburn and ulcer treatment Nexium in Germany.
A spokesman said on Friday the Anglo-Swedish company was aware that copycat versions of Nexium had arrived